Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-921-2013

Drug recall · September 4, 2013

Bethel 30 capsules recall

Why: Marketed Without An Approved NDA/ANDA: FDA analysis found this product contained undeclared sibutramine and phenolphthalein, two active ingredients that were once marketed in the U.S. but removed due to safety reasons, making this product an unapproved new drug.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Bethel 30 capsules, packaged in 30 count bottles, Distributed by BETHEL INC. New York, New York

Lots / codes

Lot #: 120514, EXP: 12/2014

Quantity
18,678 bottles
Company
Bethel Nutritional Consulting, Inc, New York, NY
Distribution
Nationwide. Product was also available for sale via internet
Initiated
June 11, 2013 · Voluntary: Firm initiated
Classified
August 23, 2013
Reported
September 4, 2013
Ended
June 27, 2018
How notified
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.